Tesamorelin / Ipamorelin

Product Overview

Tesamorelin 13 mg and ipamorelin 3 mg in one formulation. Research on tesamorelin examines growth hormone-releasing hormone pathways. The cited studies do not test this combined formulation or establish its properties.

Tesamorelin / Ipamorelin is listed in the EULIX Research catalog as a 13 + 3 mg research blend.

The listed formulation combines Tesamorelin 13 mg + Ipamorelin 3 mg. These quantities describe the nominal presentation; measured results belong to the individual sample report.

Review the product identity, presentation and batch documentation together when consulting analytical documentation.

Product Specifications

Compound

Tesamorelin / Ipamorelin

Presentation

13 + 3 mg

Composition

Tesamorelin 13 mg + Ipamorelin 3 mg

Form

Lyophilized material

Storage

Refer to label and batch documentation

Intended Purpose

Research and analytical use only

Brand

EULIX Research

Quality & Testing

Available analytical documentation identifies a specific sample. Review the published report for:

• Compound identification
• Batch or lot reference
• Analytical testing results
• Laboratory and report date